These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 25931577)

  • 1. INPP4B, a new player in the chemoresistance of AML.
    Recher C
    Blood; 2015 Apr; 125(18):2738-9. PubMed ID: 25931577
    [No Abstract]   [Full Text] [Related]  

  • 2. Inositol polyphosphate 4-phosphatase II (INPP4B) is associated with chemoresistance and poor outcome in AML.
    Rijal S; Fleming S; Cummings N; Rynkiewicz NK; Ooms LM; Nguyen NY; Teh TC; Avery S; McManus JF; Papenfuss AT; McLean C; Guthridge MA; Mitchell CA; Wei AH
    Blood; 2015 Apr; 125(18):2815-24. PubMed ID: 25736313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. INPP4B-mediated DNA repair pathway confers resistance to chemotherapy in acute myeloid leukemia.
    Wang P; Ma D; Wang J; Fang Q; Gao R; Wu W; Cao L; Hu X; Zhao J; Li Y
    Tumour Biol; 2016 Sep; 37(9):12513-12523. PubMed ID: 27342972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. INPP4B overexpression is associated with poor clinical outcome and therapy resistance in acute myeloid leukemia.
    Dzneladze I; He R; Woolley JF; Son MH; Sharobim MH; Greenberg SA; Gabra M; Langlois C; Rashid A; Hakem A; Ibrahimova N; Arruda A; Löwenberg B; Valk PJ; Minden MD; Salmena L
    Leukemia; 2015 Jul; 29(7):1485-95. PubMed ID: 25736236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypermethylation of CpG sites at the promoter region is associated with deregulation of mitochondrial ATPsyn-β and chemoresistance in acute myeloid leukemia.
    Yang J; Xiao X; Li R; Li Z; Deng M; Zhang G
    Cancer Biomark; 2016; 16(1):81-8. PubMed ID: 26835708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long noncoding RNAs have pivotal roles in chemoresistance of acute myeloid leukemia.
    Izadirad M; Jafari L; James AR; Unfried JP; Wu ZX; Chen ZS
    Drug Discov Today; 2021 Jul; 26(7):1735-1743. PubMed ID: 33781951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IRF2-INPP4B axis participates in the development of acute myeloid leukemia by regulating cell growth and survival.
    Zhang F; Zhu J; Li J; Zhu F; Zhang P
    Gene; 2017 Sep; 627():9-14. PubMed ID: 28579269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of three different ATP-binding cassette transporters and correlation to chemoresistance in acute myeloid leukemia.
    Palaiologou D; Panayiotidis P; Papanikolaou G; Georgiou G; Boutsikas G; Hatzinicolaou SL; Pangalis GA; Sakellaropoulos N; Vassilakopoulos TP; Angelopoulou MK
    Int J Lab Hematol; 2015 Feb; 37(1):e7-e10. PubMed ID: 24809224
    [No Abstract]   [Full Text] [Related]  

  • 9. Identifying high-risk adult AML patients: epigenetic and genetic risk factors and their implications for therapy.
    Bret C; Viziteu E; Kassambara A; Moreaux J
    Expert Rev Hematol; 2016; 9(4):351-60. PubMed ID: 26761438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic Resistance in Acute Myeloid Leukemia: The Role of Non-Coding RNAs.
    Zebisch A; Hatzl S; Pichler M; Wölfler A; Sill H
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27973410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrating resistance functions to predict response to induction chemotherapy in de novo acute myeloid leukemia.
    Chiu YC; Hsiao TH; Tsai JR; Wang LJ; Ho TC; Hsu SL; Teng CJ
    Eur J Haematol; 2019 Oct; 103(4):417-425. PubMed ID: 31356696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro all-trans retinoic acid sensitivity of acute myeloid leukemia blasts with NUP98/RARG fusion gene.
    Such E; Cordón L; Sempere A; Villamón E; Ibañez M; Luna I; Gómez-Seguí I; López-Pavía M; Alonso C; Lo-Coco F; Cervera J; Sanz MA
    Ann Hematol; 2014 Nov; 93(11):1931-3. PubMed ID: 24728721
    [No Abstract]   [Full Text] [Related]  

  • 13. Secondary resistance to sorafenib in two patients with acute myeloid leukemia (AML) harboring FLT3-ITD mutations.
    Scholl S; Spies-Weisshart B; Klink A; Muegge LO; Fricke HJ; Hochhaus A
    Ann Hematol; 2011 Apr; 90(4):473-5. PubMed ID: 20652568
    [No Abstract]   [Full Text] [Related]  

  • 14. Favorable outcomes of NPM1
    Khan I; Kaempf A; Raghuwanshi S; Chesnokov M; Zhang X; Wang Z; Domling A; Tyner JW; Camacho C; Gartel AL
    Blood Cancer J; 2023 Aug; 13(1):128. PubMed ID: 37607920
    [No Abstract]   [Full Text] [Related]  

  • 15. LncRNA KCNQ1OT1 contributes to the progression and chemoresistance in acute myeloid leukemia by modulating Tspan3 through suppressing miR-193a-3p.
    Sun H; Sun Y; Chen Q; Xu Z
    Life Sci; 2020 Jan; 241():117161. PubMed ID: 31837329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knockdown of LncRNA-UCA1 suppresses chemoresistance of pediatric AML by inhibiting glycolysis through the microRNA-125a/hexokinase 2 pathway.
    Zhang Y; Liu Y; Xu X
    J Cell Biochem; 2018 Jul; 119(7):6296-6308. PubMed ID: 29663500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SubID, a non-median dichotomization tool for heterogeneous populations, reveals the pan-cancer significance of INPP4B and its regulation by EVI1 in AML.
    Dzneladze I; Woolley JF; Rossell C; Han Y; Rashid A; Jain M; Reimand J; Minden MD; Salmena L
    PLoS One; 2018; 13(2):e0191510. PubMed ID: 29415082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TUG1 confers Adriamycin resistance in acute myeloid leukemia by epigenetically suppressing miR-34a expression via EZH2.
    Li Q; Song W; Wang J
    Biomed Pharmacother; 2019 Jan; 109():1793-1801. PubMed ID: 30551433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FOXM1 contributes to treatment failure in acute myeloid leukemia.
    Khan I; Halasi M; Patel A; Schultz R; Kalakota N; Chen YH; Aardsma N; Liu L; Crispino JD; Mahmud N; Frankfurt O; Gartel AL
    JCI Insight; 2018 Aug; 3(15):. PubMed ID: 30089730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. INPP4B reverses docetaxel resistance and epithelial-to-mesenchymal transition via the PI3K/Akt signaling pathway in prostate cancer.
    Chen H; Li H; Chen Q
    Biochem Biophys Res Commun; 2016 Aug; 477(3):467-72. PubMed ID: 27318090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.